Related Experiment Videos
Does gabapentin act as an agonist at native GABA(B) receptors?
Jen-Kun Cheng1, Sun-Zhi Lee, Jia-Rung Yang
1Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.
Journal of Biomedical Science
|April 7, 2004
Summary
Gabapentin does not activate gamma-aminobutyric acid (GABA) B receptors. This study found gabapentin ineffective in pain relief models involving GABA B receptors, unlike the known agonist baclofen.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Gabapentin, a GABA analogue, has unclear mechanisms for its anticonvulsant and analgesic effects.
- Previous research suggested gabapentin might selectively target specific GABA(B) receptor subtypes, but this remains controversial.
Purpose of the Study:
- To investigate whether gabapentin acts as an agonist at native GABA(B) receptors in vivo and in vitro.
- To clarify gabapentin's role in pain pathways involving GABA(B) receptors.
Main Methods:
- Utilized a rat model of postoperative pain and in vitro periaqueductal gray (PAG) slices.
- Administered gabapentin and baclofen (a known GABA(B) agonist) intrathecally.
- Tested GABA(B) receptor antagonists (CGP 35348, CGP 55845) and measured G-protein-coupled inwardly rectifying K(+) (GIRK) channel activity in ventrolateral PAG neurons.
Main Results:
- Both gabapentin and baclofen induced antiallodynia in the pain model.
- GABA(B) antagonists blocked baclofen's effect but not gabapentin's antiallodynia.
- Gabapentin did not affect GIRK channel currents in PAG neurons, while baclofen did, an effect blocked by antagonists.
Conclusions:
- Gabapentin is not an agonist at the functional GABA(B) receptors involved in baclofen-induced antiallodynia.
- The study concludes gabapentin does not activate GABA(B) receptors responsible for antinociception in the tested models.